Post hoc analysis of the CLEAR study in advanced renal cell carcinoma (RCC): Effect of subsequent therapy on survival outcomes in the lenvatinib (LEN) + everolimus (EVE) versus sunitinib (SUN) treatment arms Meeting Abstract
| Authors: | Hutson, T. E.; Choueiri, T. K.; Motzer, R. J.; Rha, S. Y.; Alyasova, A.; Merchan, J. R.; Gurney, H.; Peer, A.; Takagi, T.; Porta, C.; Powles, T.; Grünwald, V.; De Giorgi, U.; Vaishampayan, U. N.; Schmidinger, M.; Glen, H.; Rodriguez-Lopez, K.; Xing, D.; Dutta, L.; Eto, M. |
| Abstract Title: | Post hoc analysis of the CLEAR study in advanced renal cell carcinoma (RCC): Effect of subsequent therapy on survival outcomes in the lenvatinib (LEN) + everolimus (EVE) versus sunitinib (SUN) treatment arms |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120602310 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.4562 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4562 -- Source: Wos |
